|
|
|
|
|
|
Year: 2015 Vol. 19 Num. 4 -
Oct/Dec
DOI: 10.1055/s-0034-1397335
|
Print: |
|
|
|
|
An Aggressive Plasmablastic Lymphoma of the Oral Cavity as Primary Manifestation of Acquired Immunodeficiency Syndrome: Case Report and Literature Review |
|
How to cite this article |
Corti M, Minué G, Campitelli A, Narbaitz M, Gilardi L. An Aggressive Plasmablastic Lymphoma of the Oral Cavity as Primary Manifestation of Acquired Immunodeficiency Syndrome: Case Report and Literature Review. Int. Arch. Otorhinolaryngol. 2015;19(4):354-358 |
|
Author(s): |
Marcelo Corti, Gonzalo Minué, Ana Campitelli, Marina Narbaitz, Leonardo Gilardi
|
|
|
Key words: |
plasmablastic lymphoma - oral cavity - HIV - AIDS |
|
|
|
Abstract: |
Introduction Plasmablastic lymphoma is a rare entity that was first described in the jaws and the oral cavity of patients with human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS). Plasmablastic lymphoma is considered as a diffuse, large, B-cell lymphoma with a unique phenotype and a predilection for the oral cavity.
Objective The authors describe a case of an aggressive plasmablastic lymphoma of the oral cavity as the primary manifestation of AIDS.
Resumed Report We report a case of plasmablastic lymphoma involving only the oral cavity as the first manifestation of AIDS. Diagnosis was confirmed by the oral lesion biopsy and the histopathologic examination that showed a dense infiltrate composed of atypical lymphocytes with numerous plasmocytes that expressed the plasma cell markers MUM-1 and CD138 and that were negative for the B-cell markers CD3, CD20, and CD45. Immunohistochemical and in situ hybridization revealed the Epstein-Barr virus genome in the atypical cells. Polymerase chain reaction was also positive for human herpesvirus-8 RNA.
Conclusion The HIV serologic status should be evaluated in all patients with plasmablastic lymphoma of the oral cavity or extraoral sites.
|
|
|
|
|
|
|
Print: |
|
|
|
|
|
|
|
All right reserved. Prohibited the reproduction of papers
without previous authorization of FORL © 1997-
2024
|
|
|
|
|